CFRX ContraFect Corporation

0.46
+0.02  (+4%)
Previous Close 0.44
Open 0.46
Price To Book -45.7
Market Cap 36290167
Shares 79,409,556
Volume 99,412
Short Ratio
Av. Daily Volume 989,033

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 trial noted clinically meaningful data but not statistically significant.
CF-301
Serious infections caused byStaph aureus including MRSA